Treatment of patients with chronic pruritus of unknown origin with dupilumab.

CONCLUSION: This study suggests that dupilumab may be an effective treatment for patients with CPUO and supports the design of future randomized placebo-controlled trials to prove its efficacy. PMID: 33557654 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33557654?dopt=Abstract

Source: Journal of Dermatological Treatment - February 10, 2021 Category: Dermatology Tags: J Dermatolog Treat Source Type: research